Summit Therapeutics
SMMT
#1494
Rank
โ‚ฌ12.01 B
Marketcap
16,14ย โ‚ฌ
Share price
2.40%
Change (1 day)
-3.59%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: โ‚ฌ12.01 Billion

As of December 2025 Summit Therapeutics has a market cap of โ‚ฌ12.01 Billion. This makes Summit Therapeutics the world's 1494th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ12.01 B-6.9%
2024โ‚ฌ12.90 B679.89%
2023โ‚ฌ1.65 B107.45%
2022โ‚ฌ0.79 B243.67%
2021โ‚ฌ0.23 B-26.16%
2020โ‚ฌ0.31 B227.6%
2019โ‚ฌ95.94 M480.13%
2018โ‚ฌ16.53 M-88%
2017โ‚ฌ0.13 B37.73%
2016โ‚ฌ0.10 B-22.38%
2015โ‚ฌ0.12 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Summit Therapeutics was reported to be:

โ‚ฌ12.01 Billion
by Nasdaq info icon info icon
โ‚ฌ12.01 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ2.05 B-82.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚ฌ5.28 B-55.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚ฌ0.19 B-98.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚ฌ0.12 B-98.94%๐Ÿ‡บ๐Ÿ‡ธ USA